• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Peripheral Drug-Coated Balloon for Coronary Drug-Eluting Stent In-Stent Restenosis: Off-Label, Off-Target.

作者信息

Waksman Ron, Abusnina Waiel

机构信息

Section of Interventional Cardiology, MedStar Washington Hospital Center, Washington, DC.

出版信息

J Soc Cardiovasc Angiogr Interv. 2024 Feb 20;3(3Part A):101306. doi: 10.1016/j.jscai.2024.101306. eCollection 2024 Mar.

DOI:10.1016/j.jscai.2024.101306
PMID:39131783
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11308808/
Abstract
摘要

相似文献

1
Peripheral Drug-Coated Balloon for Coronary Drug-Eluting Stent In-Stent Restenosis: Off-Label, Off-Target.用于冠状动脉药物洗脱支架内再狭窄的外周药物涂层球囊：未获批准的用途，非靶向应用
J Soc Cardiovasc Angiogr Interv. 2024 Feb 20;3(3Part A):101306. doi: 10.1016/j.jscai.2024.101306. eCollection 2024 Mar.
2
Long-Term Outcomes After Treatment With a Paclitaxel-Coated Balloon Versus Balloon Angioplasty: Insights From the PEPCAD-DES Study (Treatment of Drug-eluting Stent [DES] In-Stent Restenosis With SeQuent Please Paclitaxel-Coated Percutaneous Transluminal Coronary Angioplasty [PTCA] Catheter).紫杉醇涂层球囊与球囊血管成形术治疗的长期结果：PEPCAD-DES 研究的见解（使用 SeQuent Please 紫杉醇涂层经皮腔内冠状动脉血管成形术 [PTCA] 导管治疗药物洗脱支架 [DES] 支架内再狭窄）。
JACC Cardiovasc Interv. 2015 Nov;8(13):1695-700. doi: 10.1016/j.jcin.2015.07.023.
3
Long-Term Efficacy and Safety of Paclitaxel-Eluting Balloon for the Treatment of Drug-Eluting Stent Restenosis: 3-Year Results of a Randomized Controlled Trial.紫杉醇洗脱球囊治疗药物洗脱支架再狭窄的长期疗效和安全性：一项随机对照试验的 3 年结果。
JACC Cardiovasc Interv. 2015 Jun;8(7):877-84. doi: 10.1016/j.jcin.2015.01.031. Epub 2015 May 20.
4
Paclitaxel-coated balloon catheter versus paclitaxel-coated stent for the treatment of coronary in-stent restenosis.紫杉醇涂层球囊导管与紫杉醇涂层支架治疗冠状动脉支架内再狭窄的比较。
Circulation. 2009 Jun 16;119(23):2986-94. doi: 10.1161/CIRCULATIONAHA.108.839282. Epub 2009 Jun 1.
5
A randomized, multicenter, single-blinded trial comparing paclitaxel-coated balloon angioplasty with plain balloon angioplasty in drug-eluting stent restenosis: the PEPCAD-DES study.紫杉醇涂层球囊血管成形术与普通球囊血管成形术治疗药物洗脱支架再狭窄的随机、多中心、单盲临床试验：PEPCAD-DES 研究。
J Am Coll Cardiol. 2012 Apr 10;59(15):1377-82. doi: 10.1016/j.jacc.2012.01.015. Epub 2012 Feb 29.
6
Paclitaxel-coated balloon for the treatment of drug-eluting stent restenosis: subanalysis results from the Valentines I trial.用于治疗药物洗脱支架再狭窄的紫杉醇涂层球囊：情人节 I 试验的亚组分析结果
Cardiovasc Revasc Med. 2014 Jan;15(1):23-8. doi: 10.1016/j.carrev.2013.08.011.
7
Paclitaxcel-coated balloon plus bare metal stent vs. sirolimus-eluting stent in de novo lesions: an IVUS study.紫杉醇涂层球囊联合裸金属支架与雷帕霉素洗脱支架治疗初发病变：一项血管内超声研究。
EuroIntervention. 2012 Aug;8(4):450-5. doi: 10.4244/EIJV8I4A71.
8
Sirolimus-eluting stent or paclitaxel-eluting stent vs balloon angioplasty for prevention of recurrences in patients with coronary in-stent restenosis: a randomized controlled trial.西罗莫司洗脱支架或紫杉醇洗脱支架与球囊血管成形术预防冠状动脉支架内再狭窄患者复发的随机对照试验。
JAMA. 2005 Jan 12;293(2):165-71. doi: 10.1001/jama.293.2.165.
9
Drug-eluting balloon in peripheral intervention for the superficial femoral artery: the DEBATE-SFA randomized trial (drug eluting balloon in peripheral intervention for the superficial femoral artery).药物涂层球囊外周介入治疗股浅动脉：DEBATE-SFA 随机试验（药物涂层球囊外周介入治疗股浅动脉）。
JACC Cardiovasc Interv. 2013 Dec;6(12):1295-302. doi: 10.1016/j.jcin.2013.07.010. Epub 2013 Nov 13.
10
Paclitaxel-Eluting Balloon Versus Standard Balloon Angioplasty in In-Stent Restenosis of the Superficial Femoral and Proximal Popliteal Artery: 1-Year Results of the PACUBA Trial.紫杉醇洗脱球囊与标准球囊血管成形术治疗股浅动脉和腘动脉支架内再狭窄：PACUBA 试验 1 年结果。
JACC Cardiovasc Interv. 2016 Jul 11;9(13):1386-92. doi: 10.1016/j.jcin.2016.04.012.

引用本文的文献

1
Drug-Coated Balloons for Coronary Artery Disease: From Theory to Practice.用于冠状动脉疾病的药物涂层球囊：从理论到实践
Curr Treat Options Cardiovasc Med. 2025 Dec;27(1). doi: 10.1007/s11936-025-01084-4. Epub 2025 Mar 19.

本文引用的文献

1
5-Year Outcomes of Drug-Coated Balloons for Peripheral Artery In-Stent Restenosis, Long Lesions, and CTOs.药物涂层球囊治疗外周动脉支架内再狭窄、长病变和 CTO 的 5 年结果。
JACC Cardiovasc Interv. 2023 May 8;16(9):1065-1078. doi: 10.1016/j.jcin.2023.03.032.
2
Coronary artery restenosis treatment with plain balloon, drug-coated balloon, or drug-eluting stent: 10-year outcomes of the ISAR-DESIRE 3 trial.冠状动脉再狭窄治疗：普通球囊、药物涂层球囊与药物洗脱支架的比较——ISAR-DESIRE 3 试验 10 年随访结果
Eur Heart J. 2023 Apr 17;44(15):1343-1357. doi: 10.1093/eurheartj/ehad026.
3
Understanding the Mechanism of Drug Transfer and Retention of Drug-Coated Balloons.了解药物涂层球囊药物传递和保留的机制。
J Cardiovasc Pharmacol Ther. 2022 Jan-Dec;27:10742484221119559. doi: 10.1177/10742484221119559.
4
2021 ACC/AHA/SCAI Guideline for Coronary Artery Revascularization: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.2021 ACC/AHA/SCAI 冠状动脉血运重建指南：美国心脏病学会/美国心脏协会联合临床实践指南委员会的报告。
J Am Coll Cardiol. 2022 Jan 18;79(2):e21-e129. doi: 10.1016/j.jacc.2021.09.006. Epub 2021 Dec 9.
5
Waksman In-Stent Restenosis Classification: A Mechanism-Based Approach to the Treatment of Restenosis.Waksman 支架内再狭窄分类：一种基于机制的再狭窄治疗方法。
Cardiovasc Revasc Med. 2021 Dec;33:62-67. doi: 10.1016/j.carrev.2021.06.004. Epub 2021 Jun 5.
6
Impact of Optimal Preparation Before Drug-Coated Balloon Dilatation for De Novo Lesion in Patients With Coronary Artery Disease.药物涂层球囊扩张治疗冠状动脉疾病患者初发病变前的最佳准备的影响。
Cardiovasc Revasc Med. 2022 Feb;35:91-95. doi: 10.1016/j.carrev.2021.03.012. Epub 2021 Mar 20.
7
Paclitaxel-coated balloon angioplasty vs. drug-eluting stenting for the treatment of coronary in-stent restenosis: a comprehensive, collaborative, individual patient data meta-analysis of 10 randomized clinical trials (DAEDALUS study).紫杉醇涂层球囊血管成形术与药物洗脱支架治疗冠状动脉支架内再狭窄的比较：10项随机临床试验的综合、协作、个体患者数据荟萃分析（代达罗斯研究）
Eur Heart J. 2020 Oct 7;41(38):3715-3728. doi: 10.1093/eurheartj/ehz594.
8
'Ten commandments' for the 2018 ESC/EACTS Guidelines on Myocardial Revascularization.2018年欧洲心脏病学会/欧洲心胸外科学会心肌血运重建指南的“十诫”
Eur Heart J. 2019 Jan 7;40(2):79-80. doi: 10.1093/eurheartj/ehy855.
9
Drug-Coated Balloon Angioplasty for Femoropopliteal In-Stent Restenosis.药物涂层球囊血管成形术治疗股腘段支架内再狭窄。
Circ Cardiovasc Interv. 2018 Dec;11(12):e007055. doi: 10.1161/CIRCINTERVENTIONS.118.007055.
10
Endovascular Management of Femoropopliteal In-Stent Restenosis: A Systematic Review.股腘动脉支架内再狭窄的血管内治疗：一项系统评价
Cardiovasc Revasc Med. 2019 Oct;20(10):915-925. doi: 10.1016/j.carrev.2018.10.028. Epub 2018 Nov 7.